Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products, with an emphasis on life science-based innovation and production excellence. Emerald’s three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities.

Recent News

  • Emerald Health Therapeutics Closes Shares for Debt Transaction

    Vancouver, British Columbia--(Newsfile Corp. - September 16, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has closed its previously announced shares for debt financing. Further to its news release dated August 21, 2020, the Company has settled $625,000 of debt (the "Debt") payable to the holders (the "Holders") of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures"). The Debt represents accrued interest on the Convertible Debentures to June 30, 2020....

    2020-09-16 7:47 PM ET
  • Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients

    Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) -  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to use such products for treatment purposes.STENOCARE, located in Denmark, is a leading supplier of prescription-based medical cannabis products for patient treatment to help them improve quality of life. Under an agreement...

    2020-09-10 7:00 AM ET
  • Emerald Health Therapeutics Enters into Share Purchase Agreement for Sale of Pure Sunfarms

    Vancouver, British Columbia--(Newsfile Corp. - September 8, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") is pleased to announce that it has entered into a share purchase agreement (the "Share Purchase Agreement") with Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF) ("Village Farms") in respect of the sale of the Company's interest in Pure Sunfarms Corp. ("PSF"), a joint venture that was established between the Company and Village Farms in 2017 in which the Company...

    2020-09-08 1:55 PM ET
  • Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

    Vancouver, British Columbia--(Newsfile Corp. - September 1, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") reported financial results for the three and six months ended June 30, 2020. Full versions of the Company's unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com."The second quarter was a very solid quarter in all aspects of our business. It marked a fundamental and notable shift in our financial performance; significant progress in all aspects...

    2020-09-01 7:00 AM ET
  • Emerald Health Therapeutics Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects

    Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) -  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald")  has launched the first product in its adult-use SYNCTM Nano fast-acting cannabis spray product line. SYNCTM 15 Nano THC Fast Action Spray allows consumers to choose ingestion over inhalation of cannabis while achieving a much more rapid, predictable onset and shorter controlled duration of effects compared to edibles and oils. The sublingual spray's effects can start in 10-20 minutes and last two...

    2020-08-31 7:00 AM ET
  • Emerald Health Therapeutics' Pure Sunfarms Joint Venture Begins Shipping Cannabis 2.0 Products and Bottled Oils

    Pure Sunfarms' Full Spectrum Vapes in 510 thread cartridges and Pure Sun CBD Oil to be available to consumers in British Columbia in coming days; Ontario and Alberta to followEmerald will host its 2020 second quarter financial results conference call on Tuesday, September 1, 2020 at 10:30 AM ETVancouver, British Columbia--(Newsfile Corp. - August 25, 2020) -  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has...

    2020-08-25 7:00 AM ET
  • Emerald Health Therapeutics Announces Shares for Debt Transaction

    Vancouver, British Columbia--(Newsfile Corp. - August 21, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") today announced that it has reached an agreement with the holders of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures") to settle accrued interest on the Convertible Debentures to June 30, 2020 in the amount of $625,000 by issuing an additional 3,571,428 common shares of the Company (the "Debt Shares") at a deemed value of $0.175...

    2020-08-21 9:00 PM ET
  • Emerald Health Therapeutics Reports Pure Sunfarms Second Quarter 2020 Financial Results

    Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has provided preliminary, unaudited financial results for the second quarter of 2020 for its 41.3%-owned joint venture, Pure Sunfarms."Pure Sunfarms' leadership in low-cost production enables it to offer consumers high-quality cannabis products that are well-priced. This strong competitive positioning against both licensed and unlicensed producers has enabled it to achieve leading market share in Ontario and strong growth in other provinces,"...

    2020-08-13 7:00 AM ET